2020
DOI: 10.1101/2020.10.12.20211656
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

News Coverage and Drug Shortages during the COVID-19 Pandemic

Abstract: Several drugs repurposed as COVID-19 treatment are in short supply. We collect data from MediaCloud and Google Health Trends about eight drugs proposed for repurposing as COVID-19 treatments and reported to be in shortage by the U.S. Food and Drug Administration from January 1, 2020 through June 30, 2020. We find that news media coverage could have contributed to shortages due to hoarding by individuals and stockpiling by institutions, and that search trends appear to accurately discriminate between individual… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 5 publications
0
6
0
Order By: Relevance
“…At the start of our research study, both our study’s institutions as well as centers nationally were utilizing azithromycin with or without hydroxychloroquine as medical treatment for confirmed cases of COVID-19. This widespread repurposing of azithromycin as a COVID-19 treatment resulted in national shortages of the azithromycin [ 7 , 8 ]. While published reports on this shortage of azithromycin due to COVID-19 utilization specifically in the United States are sparse, there are two recent studies [ 8 , 9 ] that highlight the shortage’s timeline and extent.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…At the start of our research study, both our study’s institutions as well as centers nationally were utilizing azithromycin with or without hydroxychloroquine as medical treatment for confirmed cases of COVID-19. This widespread repurposing of azithromycin as a COVID-19 treatment resulted in national shortages of the azithromycin [ 7 , 8 ]. While published reports on this shortage of azithromycin due to COVID-19 utilization specifically in the United States are sparse, there are two recent studies [ 8 , 9 ] that highlight the shortage’s timeline and extent.…”
Section: Resultsmentioning
confidence: 99%
“…This widespread repurposing of azithromycin as a COVID-19 treatment resulted in national shortages of the azithromycin [ 7 , 8 ]. While published reports on this shortage of azithromycin due to COVID-19 utilization specifically in the United States are sparse, there are two recent studies [ 8 , 9 ] that highlight the shortage’s timeline and extent. For example, a report by Badreldin and Attalah [ 7 ] describes the global drug shortages due to COVID-19 and the impact it had on limiting azithromycin for usual treatments secondary to its repurposing as a COVID-19 treatment.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations